Immunogen | IMGN - Процентные расходы



Процентные расходы Изменить Дата
AbbVie USD 645M 69M 2026-03
Agios Pharmaceuticals USD 1.18B 4.3B 2026-03
Amgen USD 657M 4M 2026-03
Astellas Pharma JPY 3.91B 320M 2025-03
AstraZeneca USD 484M 181M 2025-12
Bristol-Myers Squibb USD 411M 21M 2026-03
Eli Lilly USD 114.7M 134.3M 2025-09
Exelixis USD 23.4M 3.9M 2023-09
Halozyme Therapeutics USD 5.51M 597K 2026-03
Heron Therapeutics USD 600K 100K 2024-12
Intrexon USD 2K 5K 2024-06
Karyopharm Therapeutics USD 12.62M 1.24M 2025-12
MacroGenics USD 3.34M 2.54M 2025-09
Nektar Therapeutics USD 9.77M 3.75M 2025-12
Novartis USD 281M 8M 2025-09
Pfizer USD 671M 40M 2026-03
Regeneron Pharmaceuticals USD 12.9M 700K 2026-03
Roche Holding CHF 304M 7.5M 2025-06
Sanofi EUR -25M 99.78M 2025-12